Riskpilot← Back to searchSign inGet full accessORTOPHYSIO Aktiebolag
ABActiveOrg 5564331808Starrvägen 4Physiotherapy activities · NACE 8695Est. 19911 employees
Revenue 2025
SEK 829K
+9% vs 2024
EBITDA margin
40.9%
+64% vs 2024
Equity ratio
67.8%
Financial strength
Net profit 2025
SEK 86K
-44% vs 2024
| Revenue | SEK 829K | +9% |
| EBITDA | SEK 340K | +64% |
| Net profit | SEK 86K | -44% |
| Total assets | SEK 749K | +32% |
| Equity | SEK 508K | +20% |
| Employees | 1 | — |
Legal name
ORTOPHYSIO Aktiebolag
Org number
5564331808
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
1 oktober 1991
Share capital
SEK 102 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukgymnastik, utbildning inom området ergonomi, ortopedisk manuell terapi, friskvård, köp och försäljning av värdepapper, värdepappersförvaltning samt därmed förenlig verksamhet.
Address
Starrvägen 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 743 | 820 | 811 | 762 | 829 |
| Staff expenses | — | — | — | −85 | −38 |
| EBITDA | 211 | 259 | −100 | 207 | 340 |
| Depreciation & amort. | −3 | −0 | −0 | −8 | −8 |
| EBIT | 208 | 259 | −100 | 199 | 332 |
| Net financials | −5 | −2 | 246 | 3 | 5 |
| Profit before tax | 203 | 257 | 145 | 172 | 135 |
| Tax | −45 | −55 | −0 | −18 | −49 |
| Net profit | 158 | 202 | 145 | 154 | 86 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 973 | 791 | 316 | 565 | 749 |
| Equity | 612 | 665 | 268 | 422 | 508 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 361 | 126 | 48 | 113 | 164 |
| Total debt | 361 | 126 | 48 | 113 | 164 |
EBITDA margin
40.9%
This company
15.8%
Market median
+159% vs market
20212025
Equity ratio
67.8%
This company
38.2%
Market median
+77% vs market
20212025
Return on equity
16.9%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
10.3%
This company
8.1%
Market median
+27% vs market
20212025
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20212025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LT Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
GH | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Chairman | 2023 – 2023 | |
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ORTOPHYSIO Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnar Harald Johansen | Audit | 0 companies |
| Lars Thomas Wilhelm Lövgren | Chief Executive Officer | 0 companies |
| Eva Gunilla Berglind | Deputy Board Member | 0 companies |
| V E Elisabet Zetterquist Helger | Chairman | 0 companies |
| Carl Harald Daniel Zetterquist | Deputy Board Member | 0 companies |